The short version of angiotensin IV fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-05-02. Anything still debated is marked as such rather than presented as settled.
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | Derived from angiotensin IV and modified for stability. |
| Proposed mechanism | c-Met/HGF pathway activation | Described as an HGF mimetic in experimental systems. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Name usage varies by supplier and publication. |
| Regulatory status | Not approved as a drug | Sold as a research chemical in some markets. |
| Human trial data | Limited or absent | Most evidence comes from preclinical studies. |
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Regulatory treatment varies by country. Dihexa does not appear in major pharmacopeias as a licensed therapeutic substance. Suppliers may use labels such as research use only or not for human consumption. Such labels reflect legal and quality-control boundaries rather than evidence of clinical benefit. Importation, possession, and sale can be restricted depending on local laws, and enforcement focuses on claims, distribution channels, and product categories. These rules can change, and they differ from rules for approved medicines.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
The Federal Republic of Germany is a federation and consists of sixteen partly sovereign "states" (German: Länder, sing. Land). Of the 16 states, 13 are so-called "area-states" (Flächenländer); in these, below the level of the state government, there is a division into local authorities (counties and county-level cities) that have their own administration. Two states, Berlin and Hamburg, are city-states, in which there is no separation between state government and local administration. The state of Bremen is a special case: the state consists of the cities of Bremen, for which the state government also serves as the municipal administration, and Bremerhaven, which has its own local administration separate from the state government. It is therefore a mixture of a city-state and an area-state. Three states, Bavaria, Saxony, and Thuringia, use the appellation Freistaat ("free state"); this title is merely stylistic and carries no legal or political significance (similar to the US states that call themselves a commonwealth). The Federal Republic of Germany ("West Germany") was created in 1949 through the unification of the three western zones previously under American, British, and French administration in the aftermath of World War II. Initially, the states of the Federal Republic were Baden (until 1952), Bavaria (Bayern), Bremen, Hamburg, Hesse (Hessen), Lower Saxony (Niedersachsen), North Rhine-Westphalia (Nordrhein-Westfalen), Rhineland-Palatinate (Rheinland-Pfalz), Schleswig-Holstein, Württemberg-Baden (until 1952), and Württemberg-Hohenzollern (until 1952).
== Units of measurement == When referring to dietary allowances or nutritional science, retinol is usually measured in international units (IU). IU refers to biological activity and therefore is unique to each individual compound, however, 1 IU of retinol is equivalent to approximately 0.3 micrograms (300 nanograms).
=== Helmut Schmidt === Finance Minister Helmut Schmidt (SPD) formed a coalition and he served as Chancellor from 1974 to 1982. Hans-Dietrich Genscher, a leading FDP official, became Vice-Chancellor and Foreign Minister. Schmidt, a strong supporter of the European Community (EC) and the Atlantic alliance, emphasised his commitment to "the political unification of Europe in partnership with the USA". Mounting external problems forced Schmidt to concentrate on foreign policy and limited the domestic reforms that he could carry out. The USSR upgraded its intermediate-range missiles, which Schmidt complained was an unacceptable threat to the balance of nuclear power, because it increased the likelihood of political coercion and required a western response. NATO responded in the form of its twin-track policy. The domestic reverberations were serious inside the SPD, and undermined its coalition with the FDP. One of his major successes, in collaboration with French President Valéry Giscard d'Estaing, was the launching of the European Monetary System (EMS) in April 1978.
Sources: en.wikipedia.org
In lichenology, simple chemical spot tests are used to detect certain compounds in situ, and X. parietina yields clear results due to its anthraquinone pigments. A standard test is the K test (using potassium hydroxide solution). On X. parietina, applying KOH to the cortex produces a deep purple reaction (K+ purple). This is a classic indication of anthraquinones like parietin – the KOH causes parietin to form a purple salt (a distinctive color change). Other spot test results for this lichen are negative: C−, KC−, and P−. In addition to its anthraquinone pigments, Xanthoria parietina contains small amounts of calcium oxalate, a secondary metabolite that occurs in many lichens, particularly those growing on calcareous substrates. However, unlike strictly calcicolous species such as Caloplaca heppiana and Lecanora calcarea, which accumulate large quantities of calcium oxalate, X. parietina was found to contain only minor traces of this compound. This suggests that while X. parietina can tolerate limestone habitats, it does not rely on extensive oxalate production for calcium regulation or substrate modification to the same extent as obligate calcicoles.
Skin testing is also known as "puncture testing" and "prick testing" since it involves a series of tiny punctures or pricks being placed into the patient's skin. Tiny amounts of suspected allergens and/or their extracts (e.g., pollen, grass, mite proteins, peanut extract) are introduced to sites on the skin marked with pen or dye (the ink/dye should be carefully selected, lest it cause an allergic response itself). A negative and positive control are also included for comparison (e.g., negative is saline or glycerin; positive is histamine). A small plastic or metal device is used to puncture or prick the skin. Sometimes, allergens are injected "intradermally" into the patient's skin, with a needle and syringe. Common areas for testing include the inside of the forearm and the back. If the patient is allergic to the substance, then a visible inflammatory reaction will usually occur within 30 minutes. This response ranges from slight reddening of the skin to a full-blown hive (called "wheal and flare") in more sensitive patients, similar to a mosquito bite. Interpretation of the results of the skin prick test is usually done by allergists on a severity scale, with +/− meaning borderline reactivity, and 4+ representing a large reaction. Increasingly, allergists are measuring and recording the diameter of the wheal-and-flare reaction. Interpretation by well-trained allergists is often guided by relevant literature. In general, a positive response is interpreted when the wheal of an antigen is ≥3 mm larger than the wheal of the negative control (e.g., saline or glycerin).
First known as "emanation", the radioactive gas was identified during experiments with radium, thorium oxide, and actinium by Friedrich Ernst Dorn, Rutherford and Owens, and André-Louis Debierne, respectively, and each element's emanation was considered to be a separate substance: radon, thoron, and actinon. Sir William Ramsay and Robert Whytlaw-Gray considered that the radioactive emanations may contain a new element of the noble gas family, and isolated "radium emanation" in 1909 to determine its properties. In 1911, the element Ramsay and Whytlaw-Gray isolated was accepted by the International Commission for Atomic Weights, and in 1923, the International Committee for Chemical Elements and the International Union of Pure and Applied Chemistry (IUPAC) chose radon as the accepted name for the element's most stable isotope, 222Rn; thoron and actinon were also recognized by IUPAC as distinct isotopes of the element. A common source of environmental radon is uranium-containing minerals in the ground. Radon can also occur in ground water, such as spring waters and hot springs. Radon trapped in permafrost may be released by climate-change-induced thawing of permafrosts, and radon may also be released into groundwater and the atmosphere following seismic events leading to earthquakes, which has led to its investigation in the field of earthquake prediction. It is possible to test for radon in buildings, and to use techniques such as sub-slab depressurization for mitigation.
Generally, when reactions take place in the liquid and solid phases the change in volume due to reaction is not significant enough that it needs to be taken into account. Reactions in the gas phase often have significant changes in volume and in these cases one should use these modified equations.
Sources: en.wikipedia.org
=== Kidney === Regenerative capacity of the kidney has been recently explored. The basic functional and structural unit of the kidney is nephron, which is mainly composed of four components: the glomerulus, tubules, the collecting duct and peritubular capillaries. The regenerative capacity of the mammalian kidney is limited compared to that of lower vertebrates. In the mammalian kidney, the regeneration of the tubular component following an acute injury is well known. Recently regeneration of the glomerulus has also been documented. Following an acute injury, the proximal tubule is damaged more, and the injured epithelial cells slough off the basement membrane of the nephron. The surviving epithelial cells, however, undergo migration, dedifferentiation, proliferation, and redifferentiation to replenish the epithelial lining of the proximal tubule after injury. Recently, the presence and participation of kidney stem cells in the tubular regeneration has been shown. However, the concept of kidney stem cells is currently emerging. In addition to the surviving tubular epithelial cells and kidney stem cells, the bone marrow stem cells have also been shown to participate in regeneration of the proximal tubule, however, the mechanisms remain controversial. Studies examining the capacity of bone marrow stem cells to differentiate into renal cells are emerging. Like other organs, the kidney is also known to regenerate completely in lower vertebrates such as fish. Some of the known fish that show remarkable capacity of kidney regeneration are goldfish, skates, rays, and sharks.
On April 7, 1994, Federal Express Flight 705 bound for San Jose, California, experienced an attempted hijacking shortly after takeoff. FedEx employee Auburn Calloway tried to hijack the plane in order to crash it into the FedEx hub at Memphis International, in a Kamikaze-style attack. The crew—although seriously injured—fought him off and returned to Memphis, where police and emergency crews subdued him. On October 15, 2002, a Northwest Airlines Avro RJ 85 collided with the jetway at gate C2 while taxiing for a maintenance check. The mechanics were unable to slow the aircraft down in time. Due to their error, the aircraft suffered minor damage, but the number one engine was ripped almost entirely off, and the jetway. The aircraft was eventually torn apart and set in a field near the airport. On December 18, 2003, FedEx Express Flight 647 veered off the runway after the landing gear collapsed upon landing. The flight had departed Oakland International Airport (OAK) earlier that day. The aircraft was immediately engulfed in flames. All five crew members escaped by exiting via the cockpit window. On July 28, 2006, FedEx Flight 630's landing gear collapsed upon landing at Memphis International Airport after a flight from Seattle–Tacoma International Airport. After coming to a stop, the plane caught fire, engulfing the left wing and engine. While the three crew members sustained injuries, they all survived. The aircraft was written off.
== Use == The bifurcated needle is a narrow steel rod, approximately 5 cm (2 in) long with two prongs at one end. Between the two needle prongs, it can hold one dose of reconstituted freeze-dried smallpox vaccine. Up to one hundred vaccinations can be given from one vial of the reconstituted vaccine. The established technique for smallpox vaccination is to dip the needle in the vaccine, and then perpendicularly puncture a person's upper arm fifteen times rapidly in a small circular area. Though skin in the area should be clean, use of an alcohol swab is optional and if used the skin must be allowed to fully dry to avoid deactivation of the live virus vaccine. The punctures should remain in an area approximately 5 mm in diameter. The needle is then disposed of or can be sterilized for reuse given its entirely metal construction. When vaccination has been done correctly, a trace of blood appears at the vaccination site within 10 to 20 seconds after the procedure.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide derived from angiotensin IV and studied for effects on synaptic plasticity. It is often described as a hepatocyte growth factor mimetic. It is not an approved medication.
It is based on angiotensin IV, a naturally occurring peptide fragment, but dihexa itself is chemically modified and synthetic. The modifications aim to improve stability and activity compared with the parent fragment.
Laboratory studies have used cell-based assays and rodent models. These examine receptor signaling, dendritic spine changes, and behavioral tasks. Published human clinical trial data are lacking.
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.